Core Viewpoint - The company is revising its Articles of Association and certain governance systems in preparation for the issuance and listing of H shares on the Hong Kong Stock Exchange, which will take effect upon the listing date [2][4]. Summary by Sections Company Overview - The company, Kefu Medical Technology Co., Ltd., is preparing for the issuance of H shares and listing on the Hong Kong Stock Exchange [2]. Governance Revisions - The revisions to the Articles of Association and governance systems are in compliance with relevant Chinese laws and regulations, as well as the rules of the Hong Kong Stock Exchange [2][4]. - The new Articles of Association will automatically take effect upon the listing of H shares, rendering the current Articles and governance systems void [2][4]. Key Changes in Articles of Association - The registered capital of the company is stated to be RMB 208.897 million [7]. - The total number of shares after the initial public offering of H shares will be specified, with the current total being 208,897,000 shares, all of which are ordinary shares [9]. - The company will maintain compliance with the laws governing the issuance and transfer of shares, including provisions for different classes of shares and voting rights [8][10]. Shareholder Rights and Obligations - Shareholders are required to comply with laws and the Articles of Association, including obligations related to capital contributions and the prohibition of capital withdrawal [30][32]. - The company emphasizes the importance of maintaining shareholder rights and the responsibilities of controlling shareholders to protect the interests of the company and other shareholders [30][32]. Meeting and Voting Procedures - The company will adopt a hybrid format for shareholder meetings, allowing for both in-person and online participation [20]. - Shareholders holding more than 10% of shares can request the convening of extraordinary general meetings, with specific procedures outlined for such requests [21][22]. Financial Assistance and Share Repurchase - The company may provide financial assistance for the acquisition of its shares, with limits set at no more than 10% of the issued share capital [10][12]. - The company is restricted from repurchasing its shares except under specific circumstances, such as capital reduction or other legal provisions [14][18].
可孚医疗: 关于修订H股发行并上市后生效的《公司章程》（草案）及公司部分治理制度（草案）的公告